Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Long-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures
PolandStudy on the Safety and Effectiveness of Berubicin for Patients with Central Nervous System Lymphomas
PolandStudy on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation
BelgiumStudy on the Safety and Effectiveness of SBT101 Gene Therapy for Adults with Adrenomyeloneuropathy
The NetherlandsStudy on Tocilizumab and Steroids for Patients with Giant Cell Arteritis and Cerebrovascular Involvement
FranceStudy on Long-term Safety and Efficacy of Mexiletine for Children with Myotonic Disorders
FranceStudy on the Effects of Ribitol (BBP-418) in Patients with Limb Girdle Muscular Dystrophy Type 2I
DenmarkStudy on the Effects and Safety of Piromelatine for Patients with Idiopathic Rapid Eye Movement Behavior Disorder (iRBD)
AustriaStudy on the Effects of Dimethyl Fumarate for Patients with Adrenomyeloneuropathy
SpainStudy of NIDO-361 for Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
DenmarkStudy on the Effects of Satralizumab for Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
FranceStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
